Oropharyngeal Airway and Airway Complications
Launched by AGA KHAN UNIVERSITY · Jan 31, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how to safely remove a device called a Laryngeal Mask Airway (LMA) in children who are under deep anesthesia. The LMA helps keep the airway open during surgery, but how it is removed can affect whether the child experiences complications afterwards. The study aims to find out if using an additional device called an oropharyngeal airway during the removal process can help reduce issues like difficulty breathing or other airway problems.
Children aged 2 to 10 years who are generally healthy and scheduled for surgery that requires an LMA might be eligible to participate. However, those with certain conditions, like active respiratory infections or surgeries that could contaminate the airway, will not be included. If your child takes part in this study, they will have their airway monitored closely after the LMA is removed to see if there are fewer complications when the oropharyngeal airway is used. This research is important because it may help improve the safety of anesthesia practices in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I and II patients aged 2-10 years undergoing surgery where anaesthesia with LMA is considered appropriate.
- Exclusion Criteria:
- • Patients undergoing surgery involving soiling of the airway
- • Patients with conditions associated with higher incidence of gastrooseophageal reflux
- • Presence of active upper respiratory tract infection (URI)
- • Emergency Surgery
About Aga Khan University
Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials